NEOGEN Neogen Chemicals Q4 FY26 results (Jan–Mar 2026) and concall
Neogen Chemicals delivered a strong financial performance in Q4 FY26, with significant revenue and EBITDA growth, supported by sustained demand and high plant utilization. The company made substantial progress on its battery chemicals projects at Pakhajan and Dahej, despite revised timelines and increased capex, which are funded by equity infusions and insurance proceeds. While facing global chemical industry headwinds, Neogen remains confident in its long-term growth trajectory, projecting substantial revenue increases by FY29.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 833.3%, net profit up 200.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 22 | -3 | 5 | 7 | 8 −64% | 22 +833% |
| EBITDA | 38 | 41 | 35 | 35 | 36 −5% | 45 +10% |
| Net profit | 14 | 5 | 14 | 9 | 9 −36% | 15 +200% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
